Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Jackson

Showing results (71-80 of 118) with videos related to

Pageof 12
Sort By:
Investigative Ophthalmology & Visual Science|July 27, 2018
Modulating Contact Lens Discomfort With Anti-Inflammatory Approaches: A Randomized Controlled TrialLaura E Downie, Anne Gad, Chinn Yi Wong, et al.
The Journal of Biological Chemistry|February 16, 2011
A modular approach to assembly of totally synthetic self-adjuvanting lipopeptide-based vaccines allows conformational epitope buildingWeiguang Zeng, Kylie J Horrocks, Gorjana Robevska, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2004
A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responsesDavid C Jackson, Yuk Fai Lau, Thuy Le, et al.
The Journal of Clinical Investigation|May 3, 2003
Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptideNathan R Martinez, Petra Augstein, Antonis K Moustakas, et al.
Virology|March 12, 2002
Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapyJoseph Torresi, Linda Earnest-Silveira, Georgia Deliyannis, et al.
Journal of Translational Medicine|October 12, 2018
A lipidated bi-epitope vaccine comprising of MHC-I and MHC-II binder peptides elicits protective CD4 T cell and CD8 T cell immunity against Mycobacterium tuberculosisPradeep K Rai, Sathi Babu Chodisetti, Sudeep K Maurya, et al.
Hepatology (Baltimore, Md.)|March 30, 2007
A self-adjuvanting multiepitope immunogen that induces a broadly cross-reactive antibody to hepatitis C virusJoseph Torresi, Owen M Stock, Alexandra E Fischer, et al.
Vaccine|August 17, 2015
Establishment of functional influenza virus-specific CD8(+) T cell memory pools after intramuscular immunizationZhongfang Wang, Brendon Y Chua, Javier Vega Ramos, et al.
Biochimie|June 15, 2010
Identification of key residues involved in fibril formation by the conserved N-terminal region of Plasmodium falciparum merozoite surface protein 2 (MSP2)Xiaodong Yang, Christopher G Adda, Christopher A MacRaild, et al.
Viral Immunology|March 1, 2018
Antibody Responses to a Quadrivalent Hepatitis C Viral-Like Particle Vaccine Adjuvanted with Toll-Like Receptor 2 AgonistsDale Christiansen, Linda Earnest-Silveira, Brendon Chua, et al.
Pageof 12

Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
Investigative Ophthalmology & Visual Science|July 27, 2018
Modulating Contact Lens Discomfort With Anti-Inflammatory Approaches: A Randomized Controlled TrialLaura E Downie, Anne Gad, Chinn Yi Wong, et al.
The Journal of Biological Chemistry|February 16, 2011
A modular approach to assembly of totally synthetic self-adjuvanting lipopeptide-based vaccines allows conformational epitope buildingWeiguang Zeng, Kylie J Horrocks, Gorjana Robevska, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2004
A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responsesDavid C Jackson, Yuk Fai Lau, Thuy Le, et al.
The Journal of Clinical Investigation|May 3, 2003
Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptideNathan R Martinez, Petra Augstein, Antonis K Moustakas, et al.
Virology|March 12, 2002
Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapyJoseph Torresi, Linda Earnest-Silveira, Georgia Deliyannis, et al.
Journal of Translational Medicine|October 12, 2018
A lipidated bi-epitope vaccine comprising of MHC-I and MHC-II binder peptides elicits protective CD4 T cell and CD8 T cell immunity against Mycobacterium tuberculosisPradeep K Rai, Sathi Babu Chodisetti, Sudeep K Maurya, et al.
Hepatology (Baltimore, Md.)|March 30, 2007
A self-adjuvanting multiepitope immunogen that induces a broadly cross-reactive antibody to hepatitis C virusJoseph Torresi, Owen M Stock, Alexandra E Fischer, et al.
Vaccine|August 17, 2015
Establishment of functional influenza virus-specific CD8(+) T cell memory pools after intramuscular immunizationZhongfang Wang, Brendon Y Chua, Javier Vega Ramos, et al.
Biochimie|June 15, 2010
Identification of key residues involved in fibril formation by the conserved N-terminal region of Plasmodium falciparum merozoite surface protein 2 (MSP2)Xiaodong Yang, Christopher G Adda, Christopher A MacRaild, et al.
Viral Immunology|March 1, 2018
Antibody Responses to a Quadrivalent Hepatitis C Viral-Like Particle Vaccine Adjuvanted with Toll-Like Receptor 2 AgonistsDale Christiansen, Linda Earnest-Silveira, Brendon Chua, et al.
Pageof 12